biometrics
Well-Known Member
- Joined
- Oct 17, 2019
- Messages
- 20,270
Guess you know better than our scientists.It's just fine for the SA variant.
Guess you know better than our scientists.It's just fine for the SA variant.
Said like a true Brit.It's just fine for the SA variant.
Guess you know better than our scientists.
I guess that is why most European countries stopped using it.It still prevents serious/hospitalisation level infections on all variants afaik. Even according to the SA report, none of those who caught COVID after being vaccinated needed hospitalisation.
Citation needed.It still prevents serious/hospitalisation level infections on all variants afaik. Even according to the SA report, none of those who caught COVID after being vaccinated needed hospitalisation.
I guess that is why most European countries stopped using it.
Citation needed.
I guess that is why most European countries stopped using it.
Newsdeck: AstraZeneca vaccine’s global rollout faces more complications
March 25 (Reuters) - The rollout of AstraZeneca's COVID-19 vaccine, the shot much of the world is relying on to beat the pandemic, faced further complications on Thursday as India halted exports of the vaccine and Europe discussed its own export controls.www.dailymaverick.co.za
AstraZeneca revises down its vaccine efficacy in a huge US trial, to 76% from 79%, following concerns from Fauci and other experts that the results were outdated
AstraZeneca said Thursday in updated results that its COVID-19 vaccine was still 100% effective at preventing severe disease and hospitalization.www.businessinsider.co.za
Denmark prolongs suspension of AstraZeneca COVID-19 vaccine
COPENHAGEN — Danish officials decided Thursday to prolong their suspension of the AstraZeneca COVID-19 vaccine by three weeks while they continue evaluating a potential link with blood clots even though European Union regulators who looked into the iwww.coastreporter.net
New problems erode confidence in AstraZeneca's vaccine | Science
science.sciencemag.org
Yup. Anything that reduces the risk of serious illness is a winner IMHO. Not going to quibble over a few percent here or there.None of that refutes or even covers the fact it’s still considered to be suitable for preventing serious cases of COVID.
I don’t even have a dog in this fight, I had the Pfizer vaccine, but if I’d been offer the AZ one I’d definitely have still taken it.
Did you read it, you are proving my pointA quick Google later, here’s one
Is AstraZeneca's Covid jab effective against the South African variant?
The AstraZeneca vaccine has been under attack ever since the results of its phase three trials were announced in December. When the results of US trials were released this week showing 79 per cent efficacy against symptomatic disease and 100 per cent protection from serious cases of Covid 19 –...www.spectator.co.uk
The South African trial looks worrying, but what we don’t know is how effective the AstraZeneca vaccine is at preventing serious cases of Covid-19. None of the 42 cases of Covid-19 in the South African study required hospitalisation. That is not altogether surprising, given that the participants were all aged under 65 and had a median age of 30.
If the vaccine prevents serious illness from the South African variant – and it has already proved itself very good at preventing serious cases of disease in other countries where the South African variant is less prevalent – it would still be doing an extremely valuable job.
Well guess you're not coming for a holiday soon.It was AZ.
December.Well guess you're not coming for a holiday soon.
Hopefully we'll have a substantial % vaccinated by then so it's shouldn't be a big deal anymore.December.
Lol.Hopefully we'll have a substantial % vaccinated by then so it's shouldn't be a big deal anymore.
Luckily I fall into phase 2 due to co-morbidities.Lol.
Ever the optimist.
I hope you're right.
Yeah I think that's why I got an invite so quickly after getting into the system.Luckily I fall into phase 2 due to co-morbidities.
Did you read it, you are proving my point
The South African trial looks worrying, but what we don’t know is how effective the AstraZeneca vaccine is at preventing serious cases of Covid-19. None of the 42 cases of Covid-19 in the South African study required hospitalisation.